Chauvet, Sophie <br/><br/>
Treatment of B-cell disorder improves renal outcome of patients with monoclonal gammopathy-associated C3 glomerulopathy.  [electronic resource] 

 -  Blood  03 2017 
 - 1437-1447 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1528-0020 
<br/><br/><label>Standard No.: </label>10.1182/blood-2016-08-737163  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>B-Lymphocytes--pathology<br/>Cohort Studies<br/>Complement C3--analysis<br/>Databases, Factual<br/>Drug Therapy--methods<br/>France<br/>Humans<br/>Kidney Diseases--drug therapy<br/>Kidney Glomerulus--pathology<br/>Middle Aged<br/>Molecular Targeted Therapy<br/>Paraproteinemias--complications<br/>Retrospective Studies<br/>Treatment Outcome<br/>Young Adult